All Stories

  1. Identification of prognostic variables in patients with recurrent head and neck squamous cell carcinoma treated with salvage surgery: Implications for treatment with immunotherapy
  2. Prognostic value of pretreatment peripheral blood biomarkers in patients with head and neck squamous cell carcinoma treated with chemo/bioradiotherapy
  3. Relación de la infección por el virus del papiloma humano con la aparición de segundas neoplasias y su repercusión pronóstica en los pacientes con carcinoma de orofaringe
  4. Transcriptional Expression of SLC2A3 and SDHA Predicts the Risk of Local Tumor Recurrence in Patients with Head and Neck Squamous Cell Carcinomas Treated Primarily with Radiotherapy or Chemoradiotherapy
  5. Análisis de la supervivencia de los pacientes con tumores malignos de cabeza y cuello diagnosticados durante la pandemia de COVID-19
  6. Survival of patients with malignant head and neck tumors diagnosed during the COVID-19 pandemic
  7. Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma
  8. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma
  9. External validation of the GETTEC algorithm for elective neck dissection in patients candidates for salvage total laryngectomy
  10. External validation of the H‐index (host index) in patients with head and neck squamous cell carcinomas
  11. Concordance of p16INK4a and E6*I mRNA among HPV-DNA-Positive Oropharyngeal, Laryngeal, and Oral Cavity Carcinomas from the ICO International Study
  12. Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma
  13. Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy
  14. The extended SCIP flap: an anatomical and clinical study of a new SCIP flap design
  15. Semaphorin-3F/Neuropilin-2 Transcriptional Expression as a Predictive Biomarker of Occult Lymph Node Metastases in HNSCC
  16. A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
  17. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma
  18. Relationship between the transcriptional expression of PIM1 and local control in patients with head and neck squamous cell carcinomas treated with radiotherapy
  19. Causes of long-term mortality in patients with head and neck squamous cell carcinomas
  20. Anatomic mapping of the collateral branches of the external carotid artery with regard to daily clinical practice
  21. Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors
  22. Predictive value of transcriptional expression of Krüppel-like factor-6 (KLF6) in head and neck carcinoma patients treated with radiotherapy
  23. Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker
  24. The Effect of Perioperative Blood Transfusions on Microvascular Anastomoses
  25. The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients
  26. Oral cavity colon adenocarcinoma metastases: case report with surgical approach and review of more than 30 years literature
  27. Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV ‐negative head and neck squamous cell carcinoma patients
  28. Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma
  29. Indications and results of extended total laryngectomy with en-bloc resection of overlying cervical skin
  30. The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial‐like head and neck carcinoma subtypes
  31. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status
  32. Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma
  33. Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients
  34. Prognostic role of extracapsular spread in planned neck dissection after chemoradiotherapy
  35. Impacto de la laringectomía total en la situación laboral
  36. Prognostic value of CD45 transcriptional expression in head and neck cancer
  37. Prognostic relevance of insulin resistance on disease-free survival in head and neck squamous cell carcinomas: Preliminary results
  38. Validation of the pathological classification of lymph node metastasis for head and neck tumors according to the 8th edition of the TNM Classification of Malignant Tumors
  39. The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma
  40. Relationship between response to induction chemotherapy and disease control in patients with advanced laryngeal carcinoma included in an organ preservation protocol
  41. Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study
  42. Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area
  43. The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma
  44. Nodules en cavité orale, pharynx et larynx
  45. Oral cavity, pharynx and larynx nodules
  46. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer
  47. Prognostic significance of extracapsular spread in isolated neck recurrences in head and neck squamous cell carcinoma patients
  48. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy
  49. Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma
  50. Management of recurrent head and neck cancer: variables related to salvage surgery
  51. Expresión de Heat Shock Protein-90 (HSP-90) como factor predictor de la respuesta a radioterapia en pacientes con tumores de cabeza y cuello
  52. Classification of parotidectomies: a proposal of the European Salivary Gland Society
  53. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients
  54. External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma
  55. CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma
  56. Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma
  57. Reconstrucción de defectos de cavidad oral con colgajos tipo FAMM (colgajo músculo-mucoso de arteria facial). Nuestra experiencia
  58. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients
  59. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy
  60. Tratamiento quirúrgico de los carcinomas escamosos de cabeza y cuello en España durante el periodo 2006-2011
  61. Management of Sinonasal Mucosal Melanomas and Comparison of Classification Staging Systems
  62. Parotid Incidentaloma Identified by Positron Emission/Computed Tomography: When to Consider Diagnoses Other than Warthin Tumor
  63. Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy
  64. Stomal recurrence in head and neck cancer patients with temporary tracheostomy
  65. Reply to letter to the editor
  66. Etiología y tratamiento de la parálisis laríngea: estudio retrospectivo de 108 pacientes
  67. Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer
  68. High RAB 25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma
  69. Elective treatment of the neck for second primary tumors of the head and neck
  70. Adherencia crónica al humidificador de traqueostoma en pacientes laringectomizados
  71. Inclusion of Extracapsular Spread in the pTNM Classification System
  72. Prognostic role of MMP-9 expression in head and neck carcinoma patients treated with radiotherapy or chemoradiotherapy
  73. Endonasal Endoscopic Scalpel-Forceps Dacryocystorhinostomy vs Endocanalicular Diode Laser Dacryocystorhinostomy
  74. Delayed carotid blow-out syndrome: a new complication of chemoradiotherapy treatment in pharyngolaryngeal carcinoma
  75. Prognostic factors in head and neck squamous cell carcinoma: Comparison of CHAID decision trees technology and cox analysis
  76. Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma
  77. Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy
  78. Comparison of Chi-Squared Automatic Interaction Detection Classification Trees vs TNM Classification for Patients With Head and Neck Squamous Cell Carcinoma
  79. Second, third, and fourth head and neck tumors. A progressive decrease in survival
  80. Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2
  81. Sarcomas de cabeza y cuello. Nuestra experiencia
  82. Total or subtotal glossectomy with microsurgical reconstruction: Functional and oncological results
  83. Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation
  84. Extended deep inferior epigastric artery perforator flap for head and neck reconstruction: A clinical experience with 100 patients
  85. Salvage surgery after locoregional failure in head and neck carcinoma patients treated with chemoradiotherapy
  86. Risk of third and fourth tumors in patients with head and neck cancer
  87. Management of Sinonasal Inverted Papillomas and Comparison of Classification Staging Systems
  88. Parotidectomías en tumores benignos: clasificación «Sant Pau» de la extensión de la resección
  89. Tratamiento endoscópico combinado vs. abierto en el divertículo de Zenker
  90. Resultados de un protocolo de preservación de órgano en pacientes con tumores localmente avanzados de la laringe
  91. Ceratocricoid muscle: An embryological and anatomical study
  92. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case–control study
  93. Prostaglandin E2pathway in head and neck squamous cell carcinoma
  94. Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer
  95. Colgajo de pectoral mayor
  96. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies
  97. Trasplante de la laringe: ¿una opción terapéutica para el siglo XXI? Revisión de la literatura
  98. Potential Structures That Could Be Confused With a Nonrecurrent Inferior Laryngeal Nerve: An Anatomic Study
  99. Recurrent laryngeal squamous cell carcinoma: rTNM versus composite laryngeal recurrence staging system. Proposal for a modification of the CLRSS to improve patient classification
  100. Modalidades de preservación de órgano en carcinomas de laringe e hipofaringe
  101. External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy
  102. Supracricoid laryngectomy as salvage surgery after failure of radiation therapy
  103. Organ Preservation in Laryngeal and Hypopharyngeal Cancer
  104. A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy
  105. Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas
  106. Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma
  107. Incidence and Significance of Clinically Unsuspected Thyroid Tissue in Lymph Nodes Found During Neck Dissection in Head and Neck Carcinoma Patients
  108. Variability in Nerve Patterns of the Adductor Muscle Group Supplied by the Recurrent Laryngeal Nerve
  109. Laryngeal cancer in non-smoking and non-drinking patients
  110. Is dissection of level V necessary in patients with T2–T4N0 supraglottic cancer?
  111. Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma
  112. Variability of the Nerve Supply Patterns of the Human Posterior Cricoarytenoid Muscle
  113. Is the External Laryngeal Nerve an Exclusively Motor Nerve? The Cricothyroid Connection Branch
  114. The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy
  115. Second Primary Tumors in Head and Neck Cancer Patients
  116. Results of salvage surgery for local or regional recurrence after larynx preservation with induction chemotherapy and radiotherapy
  117. Selective dissection of levels II-III with intraoperative control of the upper and middle jugular nodes: A therapeutic option for the no neck
  118. An anatomical study of anastomoses between the laryngeal nerves
  119. Foramen Thyroideum: A Comparative Study in Embryos, Fetuses, and Adults